Patents by Inventor Pietari Aleksis Kokko

Pietari Aleksis Kokko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11839717
    Abstract: A method for automatically controlling ventilation of a patient includes receiving a target expiratory CO2 concentration, measuring an actual expiratory CO2, and comparing the actual expiratory CO2 concentration to the target expiratory CO2. A ventilation rate for the patient is then calculated based on the comparison of the actual expiratory CO2 concentration and the target expiratory CO2 in order to maintain the actual expiratory CO2 within a predetermined range of the target expiratory CO2. The patient is then automatically ventilated based on the calculated ventilation rate.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: December 12, 2023
    Assignee: General Electric Company
    Inventors: Erkki Paavo Heinonen, Tom Jakob Haggblom, Pietari Aleksis Kokko
  • Patent number: 9775959
    Abstract: A method for automatically controlling ventilation of a patient includes receiving a target expiratory CO2 concentration, measuring an actual expiratory CO2, and comparing the actual expiratory CO2 concentration to the target expiratory CO2. A ventilation rate for the patient is then calculated based on the comparison of the actual expiratory CO2 concentration and the target expiratory CO2 in order to maintain the actual expiratory CO2 within a predetermined range of the target expiratory CO2. The patient is then automatically ventilated based on the calculated ventilation rate.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: October 3, 2017
    Assignee: General Electric Company
    Inventor: Pietari Aleksis Kokko
  • Patent number: 9649063
    Abstract: A method and system for monitoring a patient under anesthesia involves determining a drug sensitivity index for the patient. Patient demographic information and amount of anesthetic information is obtained, wherein the amount of anesthetic information includes each drug administered to the patient and the dose amount thereof. An effect site concentration, which represents a total anesthetic concentration in a patient's brain, is then estimated based on the anesthetic information. An expected response is determined based on the demographic information and the effect site concentration. Physiological data is recorded from sensors mounted to a patient, and a depth of anesthesia is determined based on physiological data. An actual response of the patient is then determined based on the depth of anesthesia and the effect site concentration. Finally, a drug sensitivity index is determined for the patient by comparing the expected response to the actual response.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: May 16, 2017
    Assignee: General Electric Company
    Inventor: Pietari Aleksis Kokko
  • Publication number: 20160184540
    Abstract: A method for automatically controlling ventilation of a patient includes receiving a target expiratory CO2 concentration, measuring an actual expiratory CO2, and comparing the actual expiratory CO2 concentration to the target expiratory CO2. A ventilation rate for the patient is then calculated based on the comparison of the actual expiratory CO2 concentration and the target expiratory CO2 in order to maintain the actual expiratory CO2 within a predetermined range of the target expiratory CO2. The patient is then automatically ventilated based on the calculated ventilation rate.
    Type: Application
    Filed: December 30, 2014
    Publication date: June 30, 2016
    Applicant: GENERAL ELECTRIC COMPANY
    Inventor: Pietari Aleksis Kokko
  • Publication number: 20160184546
    Abstract: A method for automatically controlling ventilation of a patient includes receiving a target expiratory CO2 concentration, measuring an actual expiratory CO2, and comparing the actual expiratory CO2 concentration to the target expiratory CO2. A ventilation rate for the patient is then calculated based on the comparison of the actual expiratory CO2 concentration and the target expiratory CO2 in order to maintain the actual expiratory CO2 within a predetermined range of the target expiratory CO2. The patient is then automatically ventilated based on the calculated ventilation rate.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 30, 2016
    Inventors: Erkki Paavo Heinonen, Tom Jakob Haggblom, Pietari Aleksis Kokko
  • Publication number: 20150164412
    Abstract: A method and system for monitoring a patient under anesthesia involves determining a drug sensitivity index for the patient. Patient demographic information and amount of anesthetic information is obtained, wherein the amount of anesthetic information includes each drug administered to the patient and the dose amount thereof. An effect site concentration, which represents a total anesthetic concentration in a patient's brain, is then estimated based on the anesthetic information. An expected response is determined based on the demographic information and the effect site concentration. Physiological data is recorded from sensors mounted to a patient, and a depth of anesthesia is determined based on physiological data. An actual response of the patient is then determined based on the depth of anesthesia and the effect site concentration. Finally, a drug sensitivity index is determined for the patient by comparing the expected response to the actual response.
    Type: Application
    Filed: December 16, 2013
    Publication date: June 18, 2015
    Applicant: GENERAL ELECTRIC COMPANY
    Inventor: Pietari Aleksis Kokko